Akebia Therapeutics (AKBA) Selling, General & Administrative (2013 - 2026)
Akebia Therapeutics' Selling, General & Administrative was $28.17 million in Q2 2026, up 6.1% from $26.56 million a year earlier but down 7.4% from the prior quarter.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Selling, General & Administrative (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, Akebia Therapeutics' Selling, General & Administrative was $113.79 million through Jun 30, 2026, up 6.9% year-over-year; for FY2025, it was $107.48 million, up 0.9% from FY2024.
- Selling, General & Administrative shows a five-year compound annual growth rate of -7.0% (FY2020 to FY2025).
- In earlier years, Selling, General & Administrative was $106.55 million in FY2024 (+6.3%), $100.23 million in FY2023 (-27.7%), $138.6 million in FY2022 (-20.4%) and $174.14 million in FY2021 (+13.0%).
- Quarterly Selling, General & Administrative has moved between $22.71 million (Q3 2023) and $46.36 million (Q3 2021) over five years.
- Compared with a year earlier, Selling, General & Administrative was higher in six of the last eight quarters, with growth averaging 6.7%.
- The best year-over-year quarter for Selling, General & Administrative over five years was Q1 2026 (growth of 18.2%); the worst was Q1 2023 (a decline of 43.8%).
- Per Business Quant data, AKBA's Selling, General & Administrative in the three quarters before Q2 2026 was $30.44 million (Q1 2026), $26.09 million (Q4 2025) and $29.09 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Akebia Therapeutics | 236.42 Mn | -433.06 Mn | 38.70 Mn | 28.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.17 Mn |
| Mar 31, 2026 | 30.44 Mn |
| Dec 31, 2025 | 26.09 Mn |
| Sep 30, 2025 | 29.09 Mn |
| Jun 30, 2025 | 26.56 Mn |
| Mar 31, 2025 | 25.74 Mn |
| Dec 31, 2024 | 27.68 Mn |
| Sep 30, 2024 | 26.52 Mn |
| Jun 30, 2024 | 26.92 Mn |
| Mar 31, 2024 | 25.44 Mn |
| Dec 31, 2023 | 25.44 Mn |
| Sep 30, 2023 | 22.71 Mn |
| Jun 30, 2023 | 27.04 Mn |
| Mar 31, 2023 | 25.05 Mn |
| Dec 31, 2022 | 29.91 Mn |
| Sep 30, 2022 | 31.89 Mn |
| Jun 30, 2022 | 32.24 Mn |
| Mar 31, 2022 | 44.57 Mn |
| Dec 31, 2021 | 44.80 Mn |
| Sep 30, 2021 | 46.36 Mn |
API Access
Akebia Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();